Accrued Liabilities - Cutia Therapeutics (HKEX:2487) - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28%
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Cutia Therapeutics
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cutia Therapeutics
Accrued Liabilities Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
Cutia Therapeutics
HKEX:2487
Accrued Liabilities
ÂĄ48.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accrued Liabilities
ÂĄ2.6B
CAGR 3-Years
49%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Accrued Liabilities
ÂĄ2.2B
CAGR 3-Years
38%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Accrued Liabilities
ÂĄ134.4m
CAGR 3-Years
57%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accrued Liabilities
ÂĄ268.5m
CAGR 3-Years
37%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accrued Liabilities
ÂĄ325.2m
CAGR 3-Years
-23%
CAGR 5-Years
21%
CAGR 10-Years
45%

See Also

What is Cutia Therapeutics's Accrued Liabilities?
Accrued Liabilities
48.6m CNY

Based on the financial report for Dec 31, 2023, Cutia Therapeutics's Accrued Liabilities amounts to 48.6m CNY.

What is Cutia Therapeutics's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 1Y
30%

Over the last year, the Accrued Liabilities growth was 30%.

Back to Top